141 – Hemospray for GI bleeding; atezolizumab priority review in initial NSCLC; FDA requiring restaurants to post calorie counts
Archived series ("Inactive feed" status)
When? This feed was archived on October 07, 2018 00:40 (). Last successful fetch was on August 31, 2018 22:03 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 205334059 series 1587676
May 8, 2018
Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com
1:25 FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606799.htm
3:10 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer https://www.roche.com/media/store/releases/med-cor-2018-05-07.htm
5:45 FDA requiring restaurants to post calorie counts https://www.upi.com/FDA-requiring-restaurants-to-post-calorie-counts/6511525699017/ https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606694.htm
Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.
Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
100 episodes